NYSEARCA:IDIV Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 (IDIV) Price, Holdings, & News → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free IDIV Stock Alerts $6.96 -0.10 (-1.42%) (As of 12/9/2022) Add Compare Share Share Today's Range$6.96▼$7.0550-Day Range$6.96▼$6.9652-Week Range$6.70▼$10.76Volume10,200 shsAverage Volume27,145 shsMarket Capitalization$29.58 millionAssets Under Management$30.03 millionDividend Yield22.27%Net Expense Ratio0.87% Stock AnalysisStock Analysis Get Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 alerts: Email Address About Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027Read More IDIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IDIV ETF News HeadlinesMarch 29, 2024 | investing.comScotia Canadian Dividend Fund Series A (0P000071C8)December 25, 2023 | uk.investing.comDynamic Global Dividend Fund Series It (0P0000ZMVA)April 28, 2024 | WealthPress (Ad)It’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. December 23, 2023 | investing.comPacer Metaurus US Large Cap Dividend Multiplier 300 ETF (TRPL)November 16, 2023 | seekingalpha.comGQEIX GQG Partners US Select Quality Equity Fund InstSeptember 1, 2023 | wsj.comGuideStone Equity Index Fund;InvestorJuly 20, 2023 | wsj.comFidelity Advisor Series Equity Growth FundJune 17, 2023 | morningstar.comU.S. Equity FundsApril 28, 2024 | Tranzact (Ad)What is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. June 13, 2023 | seekingalpha.comBGB Blackstone Strategic Credit 2027 Term FundSee More Headlines Receive IDIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details Issuer Fund NameMetaurus US Equity Cumulative Dividends Fund Series 2027 Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IDIV Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$30.03 million Average Daily Volume$33,571.60 Discount/Premium-0.09% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares4,250,000BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 ExpensesTypeIDIVNYSEARCA ETFsAll ETFsManagement Fee0.87%0.50%0.51%Other Expenses0.00%0.64%0.58%Total Expense0.87%0.74%0.70%Fee Waiver0.00%-0.68%-0.57%Net Expense0.87%0.58%0.58% Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 (IDIV)Full Holdings Details Similar ETFsAccordant Odce Index FundNYSEARCA:ODCEXVanEck Vectors Green Bond ETF (CR)NYSEARCA:GRNBCRVanEck Vectors Green Bond ETF (RD)NYSEARCA:GRNBRDJPMorgan ActiveBuilders International Equity ETFNYSEARCA:JIDAAdvisorShares Madrona Domestic ETFNYSEARCA:FWDD IDIV ETF - Frequently Asked Questions How have IDIV shares performed in 2024? Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027's stock was trading at $6.96 at the start of the year. Since then, IDIV shares have increased by 0.0% and is now trading at $6.96. View the best growth stocks for 2024 here. What is the management fee for Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027? Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027's management fee is 0.87% and has no other recorded expenses or fee waivers. The net expense ratio for IDIV is 0.87%. What other stocks do shareholders of Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 own? Based on aggregate information from My MarketBeat watchlists, some companies that other Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 investors own include Oxford Lane Capital (OXLC), Orchid Island Capital (ORC), UBS ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN Series B (MRRL) and Holly Energy Partners (HEP). How do I buy shares of Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027? Shares of IDIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IDIV) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
